Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0000899243-22-001259

Options or other derivatives

  • Director acquired 28,598 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Imper Vera Director 2021-12-31 Grant or award · Stock Option (Right to Buy) +28,598 28,598 D
Loading xslF345X03/doc4.xml…